Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margot J Whitfeld

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Plos Medicine|November 10, 2021
Community control strategies for scabies: A cluster randomised noninferiority trialMyra Hardy, Josaia Samuela, Mike Kama, et al.
BMJ Open|September 2, 2020
Protocol for a cluster-randomised non-inferiority trial of one versus two doses of ivermectin for the control of scabies using a mass drug administration strategy (the RISE study)Susanna J Lake, Sophie L Phelan, Daniel Engelman, et al.
Plos Neglected Tropical Diseases|March 17, 2023
One versus two doses of ivermectin-based mass drug administration for the control of scabies: A cluster randomised non-inferiority trialSusanna J Lake, Daniel Engelman, Julie Zinihite, et al.
Lancet (London, England)|June 11, 2019
The public health control of scabies: priorities for research and actionDaniel Engelman, Paul T Cantey, Michael Marks, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Plos Medicine|November 10, 2021
Community control strategies for scabies: A cluster randomised noninferiority trialMyra Hardy, Josaia Samuela, Mike Kama, et al.
BMJ Open|September 2, 2020
Protocol for a cluster-randomised non-inferiority trial of one versus two doses of ivermectin for the control of scabies using a mass drug administration strategy (the RISE study)Susanna J Lake, Sophie L Phelan, Daniel Engelman, et al.
Plos Neglected Tropical Diseases|March 17, 2023
One versus two doses of ivermectin-based mass drug administration for the control of scabies: A cluster randomised non-inferiority trialSusanna J Lake, Daniel Engelman, Julie Zinihite, et al.
Lancet (London, England)|June 11, 2019
The public health control of scabies: priorities for research and actionDaniel Engelman, Paul T Cantey, Michael Marks, et al.
Pageof 3